Education
Yale University; National University of Colombia.
Yale University; National University of Colombia.
The vaccine candidate, first developed in 1987 in Colombia, was evaluated in clinical trials carried out by the World Health Organization in Gambia, Tanzania and Thailand, and had mixed results. In 2009, a comprehensive Cochrane review assessed the SPf66 as being not efficacious in Africa and Asia, and as having a low but statistically significant efficacy of 28% in South America. Today, after more than 33 years of research, there is still however no licensed malaria vaccine.
Researchers and vaccine developers have been working on many approaches to bring forward the availability of a malaria vaccine." More research and clinical trials are required for a universal vaccine to be implemented.